Excitotoxicity contributes significantly to
neuronal cell death in a number of
neurological conditions including stroke,
head trauma, and Huntington's disease.
The recent discovery of the proteins that
anchor and interact with glutamate
receptors opens for a new strategical
approach to cytoprotective therapy.
The present project aims at exploiting this
conceptual advance to provide a platform
for cytoprotective therapies that do not
interfere unduly with synaptic transmission.
Read more about the project.